J, P., G, L., CAH, T., A, D., S, E., G, G., . . . F, J. (2024). Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals. Antiviral research, 225, 105869. https://doi.org/10.1016/j.antiviral.2024.105869
Chicago Style (17th ed.) CitationJ, Pérez-Vargas, et al. "Nanomolar Anti-SARS-CoV-2 Omicron Activity of the Host-directed TMPRSS2 Inhibitor N-0385 and Synergistic Action with Direct-acting Antivirals." Antiviral Research 225 (2024): 105869. https://doi.org/10.1016/j.antiviral.2024.105869.
MLA (9th ed.) CitationJ, Pérez-Vargas, et al. "Nanomolar Anti-SARS-CoV-2 Omicron Activity of the Host-directed TMPRSS2 Inhibitor N-0385 and Synergistic Action with Direct-acting Antivirals." Antiviral Research, vol. 225, 2024, p. 105869, https://doi.org/10.1016/j.antiviral.2024.105869.